losartan has been researched along with Margins of Excision in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Margins of Excision: The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curry, DE | 1 |
| Al-Sayed, AA | 1 |
| Trites, J | 1 |
| Wheelock, M | 1 |
| Acott, PD | 1 |
| Midgen, C | 1 |
| Johnson, LB | 1 |
| Bezuhly, M | 1 |
1 other study available for losartan and Margins of Excision
| Article | Year |
|---|---|
Oral Losartan After Limited Mandibulectomy for Treatment of Desmoid-Type Fibromatosis.
Topics: Biopsy; Child, Preschool; Fibromatosis, Aggressive; Humans; Losartan; Male; Mandibular Osteotomy; Ma | 2023 |